Trevi Therapeutics Aktie
6,07
USD
-0,03
USD
-0,49
%
6,07
USD
-0,02
USD
-0,25
%
Werbung
Trevi Therapeutics Aktie Analyse
03.06.19 | Trevi Therapeutics Outperform | BMO Capital Markets | |
03.06.19 | Trevi Therapeutics Buy | Needham & Company, LLC |
Werbung
Werbung